Latest News
-
Dismay as prostate drug remains restricted
Specialists have reacted in dismay after the use of the prostate cancer drug abiraterone remained restricted in England. Read more
-
Winter risk from major cardiovascular events
Pressure on services and viruses may significantly increase the risk to patients experiencing major cardiovascular events in the winter, researchers warn today. Read more
-
How job stress threatens health
Men with cardiometabolic disease are at a raised risk of death if they experience job strain, researchers warn today. Read more
-
New approach to treatment-resistant cancer cells
A new method of altering treatment-resistant cancer cells could make them responsive again, researchers have reported. Read more
-
Uterine transplant problems catalogued
Uterus transplantation has been successful in some cases – but comes with major difficulties and side-effects, according to an analysis published today. Read more
-
Disgust could be public health tool
Humans have six common types of disgust – and these help to identify and avoid disease, according to a new analysis. Read more
-
Lymph node radiation benefits some breast cancer patients
Early stage breast cancer patients live longer when they have radiation therapy to the lymph nodes behind the breast bone and above the collar bone, according to new research. Read more
-
Growth hormone treatment tested for stroke survivors
Growth hormone treatment could help stroke survivors to regain better cognitive abilities and help them recover from fatigue, according to an experimental study. Read more
-
Green tea molecule could prevent heart attacks
A compound in green tea could be used to help prevent deaths from heart attacks and strokes caused by atherosclerosis, researchers reported today. Read more
-
Antifungal drug could halt dormant bowel cancer cells
A treatment used for toenail problems could be used to help eliminate dormant cells within bowel tumours, new research has unveiled. Read more
